EPISODE · Jul 3, 2017 · 12 MIN
Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL
from Journal of Clinical Oncology (JCO) Podcast · host Brenda J. Spiegler
Randomization to different methotrexate and steroid treatment strategies was not related to neuropsychological outcome in children treated for B-ALL, but age and insurance status were significant predictors. Read the associated article "Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia (HRALL) Randomized to Capizzi (CMTX) Versus High- Dose Methotrexate (HDMTX): A Report From the Children's Oncology Group (COG)" on JCO.org.
NOW PLAYING
Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m